BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11952563)

  • 1. Lymphoma molluscatum.
    Modschiedler K; Altenhoff J; von den Driesch P
    Br J Dermatol; 2002 Mar; 146(3):529-31. PubMed ID: 11952563
    [No Abstract]   [Full Text] [Related]  

  • 2. Molluscum contagiosum with CD30+ cell infiltration in a patient with mycosis fungoides.
    Ohata C; Fukuda S; Hashikawa K; Ishii N; Hamada T; Nakama T; Furumura M; Tsuruta D; Ohshima K; Hashimoto T
    Am J Dermatopathol; 2014 Aug; 36(8):685-7. PubMed ID: 24423931
    [No Abstract]   [Full Text] [Related]  

  • 3. Combination of local PUVA-therapy and interferon alpha-2A in the treatment of tumoral stage mycosis fungoides.
    Delpuget-Bertin N; Bernard P; Bedane C; Dang PM; Bonnetblanc JM
    Dermatology; 1996; 193(1):74-5. PubMed ID: 8864634
    [No Abstract]   [Full Text] [Related]  

  • 4. International symposium on cutaneous T cell lymphoma. Chicago, Illinois, Oct. 19-21, 1989.
    Springer EA; Kuzel TM; Rosen ST; Roenigk HH
    J Am Acad Dermatol; 1991 Jan; 24(1):136-8. PubMed ID: 1999510
    [No Abstract]   [Full Text] [Related]  

  • 5. Combination therapy of cutaneous T cell lymphoma with interferon alpha-2a and photochemotherapy.
    Stadler R; Otte HG
    Recent Results Cancer Res; 1995; 139():391-401. PubMed ID: 7597306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Trial of High-Dose Pegylated-Interferon-Alfa-2b Combined With Phototherapy in Advanced Stage Mycosis Fungoides.
    Walker CJ; Espinosa ML; Mehta-Shah N; Pro B; Guitart J; Kuzel T
    J Drugs Dermatol; 2021 Mar; 20(3):349-350. PubMed ID: 33683074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete remissions in psoralen and UV-A (PUVA)-refractory mycosis fungoides-type cutaneous T-cell lymphoma with combined interferon alfa and PUVA.
    Mostow EN; Neckel SL; Oberhelman L; Anderson TF; Cooper KD
    Arch Dermatol; 1993 Jun; 129(6):747-52. PubMed ID: 8507078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of CD56+ mycosis fungoides.
    Klekotka PA; Faulkner-Jones B; Heffernan MP
    Arch Dermatol; 2006 Oct; 142(10):1370-2. PubMed ID: 17043207
    [No Abstract]   [Full Text] [Related]  

  • 9. Effective control of rush progression of CD8+ mycosis fungoides with pegylated interferon.
    Fujimura T; Okuyama R; Hashimoto A; Watanabe H; Nakagawa S; Tagami H; Aiba S
    Acta Derm Venereol; 2006; 86(2):161-2. PubMed ID: 16648924
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypopigmented patches on the skin.
    Juhas E; English JC
    JAMA; 2013 Jan; 309(4):392-3. PubMed ID: 23340641
    [No Abstract]   [Full Text] [Related]  

  • 11. Juvenile mycosis fungoides with large-cell transformation: Successful treatment with psoralen with ultraviolet A light, interferon-alfa, and localized radiation.
    Chan WH; Lewis DJ; Hinojosa T; Curry JL; Duvic M
    Pediatr Dermatol; 2018 Jan; 35(1):e13-e16. PubMed ID: 29159918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypopigmented patches in a caucasian male: a quiz.
    Costa IM; Queiroz Zancanaro PC
    Acta Derm Venereol; 2010; 90(1):109-11. PubMed ID: 20107748
    [No Abstract]   [Full Text] [Related]  

  • 13. Oropharyngeal lichen planus associated with interferon-alpha treatment for mycosis fungoides: a rare side-effect in the therapy of cutaneous lymphomas.
    Kütting B; Böhm M; Luger TA; Bonsmann G
    Br J Dermatol; 1997 Nov; 137(5):836-7. PubMed ID: 9415261
    [No Abstract]   [Full Text] [Related]  

  • 14. [The functioning of the interferon system in mycosis fungoides patients undergoing different methods of therapy].
    Faradzhev ZG
    Vestn Dermatol Venerol; 1990; (6):4-7. PubMed ID: 2120861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lymphocytic colitis, followed by collagenous colitis, associated with mycosis fungoides-type T-cell lymphoma].
    Ouyahya F; Michenet P; Gargot D; Breteau N; Buzacoux J; Legoux JL
    Gastroenterol Clin Biol; 1993; 17(12):976-7. PubMed ID: 8125237
    [No Abstract]   [Full Text] [Related]  

  • 16. The Use of Interferons in the Treatment of Cutaneous T-Cell Lymphoma.
    Spaccarelli N; Rook AH
    Dermatol Clin; 2015 Oct; 33(4):731-45. PubMed ID: 26433845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycosis fungoides associated with Mediterranean lymphoma.
    Cassuto JP; Kövary PM; Campagni JP; Simony J; Maiolini R; Schneider M
    Arch Dermatol Res; 1981; 270(1):17-23. PubMed ID: 7259290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-alpha (INF-alpha) and etretinate in the treatment of mycosis fungoides.
    Torii H; Kaneko T; Matsuyama T; Nakanishi H; Harada S
    J Dermatol; 1994 Oct; 21(10):767-70. PubMed ID: 7798436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Topical interferon-beta: an additional treatment for ulcerated mycosis fungoides].
    Ständer H; Ständer S; Luger T; Schwarz T
    Hautarzt; 2001 Oct; 52(10):882-4. PubMed ID: 17690818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral involvement as the first extracutaneous manifestation of mycosis fungoides.
    de Quintana-Sancho A; Acebo-Mariñas E; Gardeazabal-García J; Aperribay-Esparza A
    Actas Dermosifiliogr; 2015 Oct; 106(8):693-5. PubMed ID: 26071909
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.